| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9712 |
| Human Intestinal Absorption | HIA+ | 0.9961 |
| Caco-2 Permeability | Caco2+ | 0.8401 |
| P-glycoprotein Substrate | Non-substrate | 0.6730 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9611 |
| Non-inhibitor | 0.9095 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6646 |
| Distribution |
| Subcellular localization | Lysosome | 0.8441 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8363 |
| CYP450 2D6 Substrate | Non-substrate | 0.5676 |
| CYP450 3A4 Substrate | Non-substrate | 0.7217 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5069 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9065 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.6373 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8714 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8751 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8757 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7631 |
| Non-inhibitor | 0.8353 |
| AMES Toxicity | Non AMES toxic | 0.8814 |
| Carcinogens | Non-carcinogens | 0.6629 |
| Fish Toxicity | Low FHMT | 0.5369 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9798 |
| Honey Bee Toxicity | Low HBT | 0.5000 |
| Biodegradation | Ready biodegradable | 0.6969 |
| Acute Oral Toxicity | II | 0.6343 |
| Carcinogenicity (Three-class) | Non-required | 0.7102 |